Global Anti-tumor Drug Market Research Report 2024(Status and Outlook)
Report Overview
Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.
This report provides a deep insight into the global Anti-tumor Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-tumor Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-tumor Drug market in any manner.
Global Anti-tumor Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Market Segmentation (by Type)
Cytotoxic Drugs
Non-cytotoxic Drugs
Market Segmentation (by Application)
Alkylating Agents
Anti-Metabolism Drugs
Platinum Antineoplastic Agents
Anthracycline Antitumor Drugs
Microtubule Stabilizer
Endocrine Therapy Drugs
Immunotherapy Drugs
Gene Therapy Drugs
Targeted Antineoplastic Drugs
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-tumor Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Anti-tumor drugs are for the treatment of cancer diseases. In recent years, the development of molecular oncology and molecular pharmacology has gradually clarified the nature of the tumor. The invention and application of advanced technologies such as large-scale rapid screening, combinatorial chemistry and genetic engineering have accelerated the process of drug development. The research and development of anti-tumor drugs have been into a new era.
This report provides a deep insight into the global Anti-tumor Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-tumor Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-tumor Drug market in any manner.
Global Anti-tumor Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Market Segmentation (by Type)
Cytotoxic Drugs
Non-cytotoxic Drugs
Market Segmentation (by Application)
Alkylating Agents
Anti-Metabolism Drugs
Platinum Antineoplastic Agents
Anthracycline Antitumor Drugs
Microtubule Stabilizer
Endocrine Therapy Drugs
Immunotherapy Drugs
Gene Therapy Drugs
Targeted Antineoplastic Drugs
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Anti-tumor Drug Market
- Overview of the regional outlook of the Anti-tumor Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-tumor Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Anti-tumor Drug
1.2 Key Market Segments
1.2.1 Anti-tumor Drug Segment by Type
1.2.2 Anti-tumor Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-TUMOR DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-tumor Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anti-tumor Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-TUMOR DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Anti-tumor Drug Sales by Manufacturers (2019-2024)
3.2 Global Anti-tumor Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-tumor Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-tumor Drug Sales Sites, Area Served, Product Type
3.6 Anti-tumor Drug Market Competitive Situation and Trends
3.6.1 Anti-tumor Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-tumor Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-TUMOR DRUG INDUSTRY CHAIN ANALYSIS
4.1 Anti-tumor Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-TUMOR DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTI-TUMOR DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-tumor Drug Sales Market Share by Type (2019-2024)
6.3 Global Anti-tumor Drug Market Size Market Share by Type (2019-2024)
6.4 Global Anti-tumor Drug Price by Type (2019-2024)
7 ANTI-TUMOR DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-tumor Drug Market Sales by Application (2019-2024)
7.3 Global Anti-tumor Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-tumor Drug Sales Growth Rate by Application (2019-2024)
8 ANTI-TUMOR DRUG MARKET SEGMENTATION BY REGION
8.1 Global Anti-tumor Drug Sales by Region
8.1.1 Global Anti-tumor Drug Sales by Region
8.1.2 Global Anti-tumor Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-tumor Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-tumor Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-tumor Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-tumor Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-tumor Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche
9.1.1 Roche Anti-tumor Drug Basic Information
9.1.2 Roche Anti-tumor Drug Product Overview
9.1.3 Roche Anti-tumor Drug Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Anti-tumor Drug SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Novartis
9.2.1 Novartis Anti-tumor Drug Basic Information
9.2.2 Novartis Anti-tumor Drug Product Overview
9.2.3 Novartis Anti-tumor Drug Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Anti-tumor Drug SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Celgene
9.3.1 Celgene Anti-tumor Drug Basic Information
9.3.2 Celgene Anti-tumor Drug Product Overview
9.3.3 Celgene Anti-tumor Drug Product Market Performance
9.3.4 Celgene Anti-tumor Drug SWOT Analysis
9.3.5 Celgene Business Overview
9.3.6 Celgene Recent Developments
9.4 Bristol-Myers Squibb
9.4.1 Bristol-Myers Squibb Anti-tumor Drug Basic Information
9.4.2 Bristol-Myers Squibb Anti-tumor Drug Product Overview
9.4.3 Bristol-Myers Squibb Anti-tumor Drug Product Market Performance
9.4.4 Bristol-Myers Squibb Business Overview
9.4.5 Bristol-Myers Squibb Recent Developments
9.5 Amgen
9.5.1 Amgen Anti-tumor Drug Basic Information
9.5.2 Amgen Anti-tumor Drug Product Overview
9.5.3 Amgen Anti-tumor Drug Product Market Performance
9.5.4 Amgen Business Overview
9.5.5 Amgen Recent Developments
9.6 Johnson and Johnson
9.6.1 Johnson and Johnson Anti-tumor Drug Basic Information
9.6.2 Johnson and Johnson Anti-tumor Drug Product Overview
9.6.3 Johnson and Johnson Anti-tumor Drug Product Market Performance
9.6.4 Johnson and Johnson Business Overview
9.6.5 Johnson and Johnson Recent Developments
9.7 Pfizer
9.7.1 Pfizer Anti-tumor Drug Basic Information
9.7.2 Pfizer Anti-tumor Drug Product Overview
9.7.3 Pfizer Anti-tumor Drug Product Market Performance
9.7.4 Pfizer Business Overview
9.7.5 Pfizer Recent Developments
9.8 Takeda
9.8.1 Takeda Anti-tumor Drug Basic Information
9.8.2 Takeda Anti-tumor Drug Product Overview
9.8.3 Takeda Anti-tumor Drug Product Market Performance
9.8.4 Takeda Business Overview
9.8.5 Takeda Recent Developments
9.9 Eli Lilly
9.9.1 Eli Lilly Anti-tumor Drug Basic Information
9.9.2 Eli Lilly Anti-tumor Drug Product Overview
9.9.3 Eli Lilly Anti-tumor Drug Product Market Performance
9.9.4 Eli Lilly Business Overview
9.9.5 Eli Lilly Recent Developments
9.10 AstraZeneca
9.10.1 AstraZeneca Anti-tumor Drug Basic Information
9.10.2 AstraZeneca Anti-tumor Drug Product Overview
9.10.3 AstraZeneca Anti-tumor Drug Product Market Performance
9.10.4 AstraZeneca Business Overview
9.10.5 AstraZeneca Recent Developments
9.11 Astellas
9.11.1 Astellas Anti-tumor Drug Basic Information
9.11.2 Astellas Anti-tumor Drug Product Overview
9.11.3 Astellas Anti-tumor Drug Product Market Performance
9.11.4 Astellas Business Overview
9.11.5 Astellas Recent Developments
9.12 Merck and Co
9.12.1 Merck and Co Anti-tumor Drug Basic Information
9.12.2 Merck and Co Anti-tumor Drug Product Overview
9.12.3 Merck and Co Anti-tumor Drug Product Market Performance
9.12.4 Merck and Co Business Overview
9.12.5 Merck and Co Recent Developments
9.13 Sanofi
9.13.1 Sanofi Anti-tumor Drug Basic Information
9.13.2 Sanofi Anti-tumor Drug Product Overview
9.13.3 Sanofi Anti-tumor Drug Product Market Performance
9.13.4 Sanofi Business Overview
9.13.5 Sanofi Recent Developments
9.14 Bayer
9.14.1 Bayer Anti-tumor Drug Basic Information
9.14.2 Bayer Anti-tumor Drug Product Overview
9.14.3 Bayer Anti-tumor Drug Product Market Performance
9.14.4 Bayer Business Overview
9.14.5 Bayer Recent Developments
9.15 Biogen Idec
9.15.1 Biogen Idec Anti-tumor Drug Basic Information
9.15.2 Biogen Idec Anti-tumor Drug Product Overview
9.15.3 Biogen Idec Anti-tumor Drug Product Market Performance
9.15.4 Biogen Idec Business Overview
9.15.5 Biogen Idec Recent Developments
9.16 Eisai
9.16.1 Eisai Anti-tumor Drug Basic Information
9.16.2 Eisai Anti-tumor Drug Product Overview
9.16.3 Eisai Anti-tumor Drug Product Market Performance
9.16.4 Eisai Business Overview
9.16.5 Eisai Recent Developments
9.17 Teva
9.17.1 Teva Anti-tumor Drug Basic Information
9.17.2 Teva Anti-tumor Drug Product Overview
9.17.3 Teva Anti-tumor Drug Product Market Performance
9.17.4 Teva Business Overview
9.17.5 Teva Recent Developments
9.18 Otsuka
9.18.1 Otsuka Anti-tumor Drug Basic Information
9.18.2 Otsuka Anti-tumor Drug Product Overview
9.18.3 Otsuka Anti-tumor Drug Product Market Performance
9.18.4 Otsuka Business Overview
9.18.5 Otsuka Recent Developments
10 ANTI-TUMOR DRUG MARKET FORECAST BY REGION
10.1 Global Anti-tumor Drug Market Size Forecast
10.2 Global Anti-tumor Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anti-tumor Drug Market Size Forecast by Country
10.2.3 Asia Pacific Anti-tumor Drug Market Size Forecast by Region
10.2.4 South America Anti-tumor Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anti-tumor Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Anti-tumor Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anti-tumor Drug by Type (2025-2030)
11.1.2 Global Anti-tumor Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anti-tumor Drug by Type (2025-2030)
11.2 Global Anti-tumor Drug Market Forecast by Application (2025-2030)
11.2.1 Global Anti-tumor Drug Sales (K Units) Forecast by Application
11.2.2 Global Anti-tumor Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Anti-tumor Drug
1.2 Key Market Segments
1.2.1 Anti-tumor Drug Segment by Type
1.2.2 Anti-tumor Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-TUMOR DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Anti-tumor Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Anti-tumor Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-TUMOR DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Anti-tumor Drug Sales by Manufacturers (2019-2024)
3.2 Global Anti-tumor Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Anti-tumor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Anti-tumor Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Anti-tumor Drug Sales Sites, Area Served, Product Type
3.6 Anti-tumor Drug Market Competitive Situation and Trends
3.6.1 Anti-tumor Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-tumor Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-TUMOR DRUG INDUSTRY CHAIN ANALYSIS
4.1 Anti-tumor Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-TUMOR DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTI-TUMOR DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-tumor Drug Sales Market Share by Type (2019-2024)
6.3 Global Anti-tumor Drug Market Size Market Share by Type (2019-2024)
6.4 Global Anti-tumor Drug Price by Type (2019-2024)
7 ANTI-TUMOR DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-tumor Drug Market Sales by Application (2019-2024)
7.3 Global Anti-tumor Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Anti-tumor Drug Sales Growth Rate by Application (2019-2024)
8 ANTI-TUMOR DRUG MARKET SEGMENTATION BY REGION
8.1 Global Anti-tumor Drug Sales by Region
8.1.1 Global Anti-tumor Drug Sales by Region
8.1.2 Global Anti-tumor Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Anti-tumor Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-tumor Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-tumor Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-tumor Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-tumor Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Roche
9.1.1 Roche Anti-tumor Drug Basic Information
9.1.2 Roche Anti-tumor Drug Product Overview
9.1.3 Roche Anti-tumor Drug Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Anti-tumor Drug SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Novartis
9.2.1 Novartis Anti-tumor Drug Basic Information
9.2.2 Novartis Anti-tumor Drug Product Overview
9.2.3 Novartis Anti-tumor Drug Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Anti-tumor Drug SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Celgene
9.3.1 Celgene Anti-tumor Drug Basic Information
9.3.2 Celgene Anti-tumor Drug Product Overview
9.3.3 Celgene Anti-tumor Drug Product Market Performance
9.3.4 Celgene Anti-tumor Drug SWOT Analysis
9.3.5 Celgene Business Overview
9.3.6 Celgene Recent Developments
9.4 Bristol-Myers Squibb
9.4.1 Bristol-Myers Squibb Anti-tumor Drug Basic Information
9.4.2 Bristol-Myers Squibb Anti-tumor Drug Product Overview
9.4.3 Bristol-Myers Squibb Anti-tumor Drug Product Market Performance
9.4.4 Bristol-Myers Squibb Business Overview
9.4.5 Bristol-Myers Squibb Recent Developments
9.5 Amgen
9.5.1 Amgen Anti-tumor Drug Basic Information
9.5.2 Amgen Anti-tumor Drug Product Overview
9.5.3 Amgen Anti-tumor Drug Product Market Performance
9.5.4 Amgen Business Overview
9.5.5 Amgen Recent Developments
9.6 Johnson and Johnson
9.6.1 Johnson and Johnson Anti-tumor Drug Basic Information
9.6.2 Johnson and Johnson Anti-tumor Drug Product Overview
9.6.3 Johnson and Johnson Anti-tumor Drug Product Market Performance
9.6.4 Johnson and Johnson Business Overview
9.6.5 Johnson and Johnson Recent Developments
9.7 Pfizer
9.7.1 Pfizer Anti-tumor Drug Basic Information
9.7.2 Pfizer Anti-tumor Drug Product Overview
9.7.3 Pfizer Anti-tumor Drug Product Market Performance
9.7.4 Pfizer Business Overview
9.7.5 Pfizer Recent Developments
9.8 Takeda
9.8.1 Takeda Anti-tumor Drug Basic Information
9.8.2 Takeda Anti-tumor Drug Product Overview
9.8.3 Takeda Anti-tumor Drug Product Market Performance
9.8.4 Takeda Business Overview
9.8.5 Takeda Recent Developments
9.9 Eli Lilly
9.9.1 Eli Lilly Anti-tumor Drug Basic Information
9.9.2 Eli Lilly Anti-tumor Drug Product Overview
9.9.3 Eli Lilly Anti-tumor Drug Product Market Performance
9.9.4 Eli Lilly Business Overview
9.9.5 Eli Lilly Recent Developments
9.10 AstraZeneca
9.10.1 AstraZeneca Anti-tumor Drug Basic Information
9.10.2 AstraZeneca Anti-tumor Drug Product Overview
9.10.3 AstraZeneca Anti-tumor Drug Product Market Performance
9.10.4 AstraZeneca Business Overview
9.10.5 AstraZeneca Recent Developments
9.11 Astellas
9.11.1 Astellas Anti-tumor Drug Basic Information
9.11.2 Astellas Anti-tumor Drug Product Overview
9.11.3 Astellas Anti-tumor Drug Product Market Performance
9.11.4 Astellas Business Overview
9.11.5 Astellas Recent Developments
9.12 Merck and Co
9.12.1 Merck and Co Anti-tumor Drug Basic Information
9.12.2 Merck and Co Anti-tumor Drug Product Overview
9.12.3 Merck and Co Anti-tumor Drug Product Market Performance
9.12.4 Merck and Co Business Overview
9.12.5 Merck and Co Recent Developments
9.13 Sanofi
9.13.1 Sanofi Anti-tumor Drug Basic Information
9.13.2 Sanofi Anti-tumor Drug Product Overview
9.13.3 Sanofi Anti-tumor Drug Product Market Performance
9.13.4 Sanofi Business Overview
9.13.5 Sanofi Recent Developments
9.14 Bayer
9.14.1 Bayer Anti-tumor Drug Basic Information
9.14.2 Bayer Anti-tumor Drug Product Overview
9.14.3 Bayer Anti-tumor Drug Product Market Performance
9.14.4 Bayer Business Overview
9.14.5 Bayer Recent Developments
9.15 Biogen Idec
9.15.1 Biogen Idec Anti-tumor Drug Basic Information
9.15.2 Biogen Idec Anti-tumor Drug Product Overview
9.15.3 Biogen Idec Anti-tumor Drug Product Market Performance
9.15.4 Biogen Idec Business Overview
9.15.5 Biogen Idec Recent Developments
9.16 Eisai
9.16.1 Eisai Anti-tumor Drug Basic Information
9.16.2 Eisai Anti-tumor Drug Product Overview
9.16.3 Eisai Anti-tumor Drug Product Market Performance
9.16.4 Eisai Business Overview
9.16.5 Eisai Recent Developments
9.17 Teva
9.17.1 Teva Anti-tumor Drug Basic Information
9.17.2 Teva Anti-tumor Drug Product Overview
9.17.3 Teva Anti-tumor Drug Product Market Performance
9.17.4 Teva Business Overview
9.17.5 Teva Recent Developments
9.18 Otsuka
9.18.1 Otsuka Anti-tumor Drug Basic Information
9.18.2 Otsuka Anti-tumor Drug Product Overview
9.18.3 Otsuka Anti-tumor Drug Product Market Performance
9.18.4 Otsuka Business Overview
9.18.5 Otsuka Recent Developments
10 ANTI-TUMOR DRUG MARKET FORECAST BY REGION
10.1 Global Anti-tumor Drug Market Size Forecast
10.2 Global Anti-tumor Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anti-tumor Drug Market Size Forecast by Country
10.2.3 Asia Pacific Anti-tumor Drug Market Size Forecast by Region
10.2.4 South America Anti-tumor Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Anti-tumor Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Anti-tumor Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Anti-tumor Drug by Type (2025-2030)
11.1.2 Global Anti-tumor Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Anti-tumor Drug by Type (2025-2030)
11.2 Global Anti-tumor Drug Market Forecast by Application (2025-2030)
11.2.1 Global Anti-tumor Drug Sales (K Units) Forecast by Application
11.2.2 Global Anti-tumor Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-tumor Drug Market Size Comparison by Region (M USD)
Table 5. Global Anti-tumor Drug Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Anti-tumor Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-tumor Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-tumor Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tumor Drug as of 2022)
Table 10. Global Market Anti-tumor Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-tumor Drug Sales Sites and Area Served
Table 12. Manufacturers Anti-tumor Drug Product Type
Table 13. Global Anti-tumor Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-tumor Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-tumor Drug Market Challenges
Table 22. Global Anti-tumor Drug Sales by Type (K Units)
Table 23. Global Anti-tumor Drug Market Size by Type (M USD)
Table 24. Global Anti-tumor Drug Sales (K Units) by Type (2019-2024)
Table 25. Global Anti-tumor Drug Sales Market Share by Type (2019-2024)
Table 26. Global Anti-tumor Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-tumor Drug Market Size Share by Type (2019-2024)
Table 28. Global Anti-tumor Drug Price (USD/Unit) by Type (2019-2024)
Table 29. Global Anti-tumor Drug Sales (K Units) by Application
Table 30. Global Anti-tumor Drug Market Size by Application
Table 31. Global Anti-tumor Drug Sales by Application (2019-2024) & (K Units)
Table 32. Global Anti-tumor Drug Sales Market Share by Application (2019-2024)
Table 33. Global Anti-tumor Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-tumor Drug Market Share by Application (2019-2024)
Table 35. Global Anti-tumor Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-tumor Drug Sales by Region (2019-2024) & (K Units)
Table 37. Global Anti-tumor Drug Sales Market Share by Region (2019-2024)
Table 38. North America Anti-tumor Drug Sales by Country (2019-2024) & (K Units)
Table 39. Europe Anti-tumor Drug Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Anti-tumor Drug Sales by Region (2019-2024) & (K Units)
Table 41. South America Anti-tumor Drug Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Anti-tumor Drug Sales by Region (2019-2024) & (K Units)
Table 43. Roche Anti-tumor Drug Basic Information
Table 44. Roche Anti-tumor Drug Product Overview
Table 45. Roche Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Anti-tumor Drug SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Novartis Anti-tumor Drug Basic Information
Table 50. Novartis Anti-tumor Drug Product Overview
Table 51. Novartis Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Anti-tumor Drug SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Celgene Anti-tumor Drug Basic Information
Table 56. Celgene Anti-tumor Drug Product Overview
Table 57. Celgene Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Celgene Anti-tumor Drug SWOT Analysis
Table 59. Celgene Business Overview
Table 60. Celgene Recent Developments
Table 61. Bristol-Myers Squibb Anti-tumor Drug Basic Information
Table 62. Bristol-Myers Squibb Anti-tumor Drug Product Overview
Table 63. Bristol-Myers Squibb Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Recent Developments
Table 66. Amgen Anti-tumor Drug Basic Information
Table 67. Amgen Anti-tumor Drug Product Overview
Table 68. Amgen Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Amgen Business Overview
Table 70. Amgen Recent Developments
Table 71. Johnson and Johnson Anti-tumor Drug Basic Information
Table 72. Johnson and Johnson Anti-tumor Drug Product Overview
Table 73. Johnson and Johnson Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Johnson and Johnson Business Overview
Table 75. Johnson and Johnson Recent Developments
Table 76. Pfizer Anti-tumor Drug Basic Information
Table 77. Pfizer Anti-tumor Drug Product Overview
Table 78. Pfizer Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Pfizer Business Overview
Table 80. Pfizer Recent Developments
Table 81. Takeda Anti-tumor Drug Basic Information
Table 82. Takeda Anti-tumor Drug Product Overview
Table 83. Takeda Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Takeda Business Overview
Table 85. Takeda Recent Developments
Table 86. Eli Lilly Anti-tumor Drug Basic Information
Table 87. Eli Lilly Anti-tumor Drug Product Overview
Table 88. Eli Lilly Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Eli Lilly Business Overview
Table 90. Eli Lilly Recent Developments
Table 91. AstraZeneca Anti-tumor Drug Basic Information
Table 92. AstraZeneca Anti-tumor Drug Product Overview
Table 93. AstraZeneca Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Recent Developments
Table 96. Astellas Anti-tumor Drug Basic Information
Table 97. Astellas Anti-tumor Drug Product Overview
Table 98. Astellas Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Astellas Business Overview
Table 100. Astellas Recent Developments
Table 101. Merck and Co Anti-tumor Drug Basic Information
Table 102. Merck and Co Anti-tumor Drug Product Overview
Table 103. Merck and Co Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Merck and Co Business Overview
Table 105. Merck and Co Recent Developments
Table 106. Sanofi Anti-tumor Drug Basic Information
Table 107. Sanofi Anti-tumor Drug Product Overview
Table 108. Sanofi Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Sanofi Business Overview
Table 110. Sanofi Recent Developments
Table 111. Bayer Anti-tumor Drug Basic Information
Table 112. Bayer Anti-tumor Drug Product Overview
Table 113. Bayer Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Bayer Business Overview
Table 115. Bayer Recent Developments
Table 116. Biogen Idec Anti-tumor Drug Basic Information
Table 117. Biogen Idec Anti-tumor Drug Product Overview
Table 118. Biogen Idec Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Biogen Idec Business Overview
Table 120. Biogen Idec Recent Developments
Table 121. Eisai Anti-tumor Drug Basic Information
Table 122. Eisai Anti-tumor Drug Product Overview
Table 123. Eisai Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Eisai Business Overview
Table 125. Eisai Recent Developments
Table 126. Teva Anti-tumor Drug Basic Information
Table 127. Teva Anti-tumor Drug Product Overview
Table 128. Teva Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Teva Business Overview
Table 130. Teva Recent Developments
Table 131. Otsuka Anti-tumor Drug Basic Information
Table 132. Otsuka Anti-tumor Drug Product Overview
Table 133. Otsuka Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Otsuka Business Overview
Table 135. Otsuka Recent Developments
Table 136. Global Anti-tumor Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 137. Global Anti-tumor Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Anti-tumor Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 139. North America Anti-tumor Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Anti-tumor Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 141. Europe Anti-tumor Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Anti-tumor Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 143. Asia Pacific Anti-tumor Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Anti-tumor Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 145. South America Anti-tumor Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Anti-tumor Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Anti-tumor Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Anti-tumor Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 149. Global Anti-tumor Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Anti-tumor Drug Price Forecast by Type (2025-2030) & (USD/Unit)
Table 151. Global Anti-tumor Drug Sales (K Units) Forecast by Application (2025-2030)
Table 152. Global Anti-tumor Drug Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-tumor Drug Market Size Comparison by Region (M USD)
Table 5. Global Anti-tumor Drug Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Anti-tumor Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Anti-tumor Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Anti-tumor Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-tumor Drug as of 2022)
Table 10. Global Market Anti-tumor Drug Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Anti-tumor Drug Sales Sites and Area Served
Table 12. Manufacturers Anti-tumor Drug Product Type
Table 13. Global Anti-tumor Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Anti-tumor Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Anti-tumor Drug Market Challenges
Table 22. Global Anti-tumor Drug Sales by Type (K Units)
Table 23. Global Anti-tumor Drug Market Size by Type (M USD)
Table 24. Global Anti-tumor Drug Sales (K Units) by Type (2019-2024)
Table 25. Global Anti-tumor Drug Sales Market Share by Type (2019-2024)
Table 26. Global Anti-tumor Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Anti-tumor Drug Market Size Share by Type (2019-2024)
Table 28. Global Anti-tumor Drug Price (USD/Unit) by Type (2019-2024)
Table 29. Global Anti-tumor Drug Sales (K Units) by Application
Table 30. Global Anti-tumor Drug Market Size by Application
Table 31. Global Anti-tumor Drug Sales by Application (2019-2024) & (K Units)
Table 32. Global Anti-tumor Drug Sales Market Share by Application (2019-2024)
Table 33. Global Anti-tumor Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Anti-tumor Drug Market Share by Application (2019-2024)
Table 35. Global Anti-tumor Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Anti-tumor Drug Sales by Region (2019-2024) & (K Units)
Table 37. Global Anti-tumor Drug Sales Market Share by Region (2019-2024)
Table 38. North America Anti-tumor Drug Sales by Country (2019-2024) & (K Units)
Table 39. Europe Anti-tumor Drug Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Anti-tumor Drug Sales by Region (2019-2024) & (K Units)
Table 41. South America Anti-tumor Drug Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Anti-tumor Drug Sales by Region (2019-2024) & (K Units)
Table 43. Roche Anti-tumor Drug Basic Information
Table 44. Roche Anti-tumor Drug Product Overview
Table 45. Roche Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Roche Business Overview
Table 47. Roche Anti-tumor Drug SWOT Analysis
Table 48. Roche Recent Developments
Table 49. Novartis Anti-tumor Drug Basic Information
Table 50. Novartis Anti-tumor Drug Product Overview
Table 51. Novartis Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Anti-tumor Drug SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Celgene Anti-tumor Drug Basic Information
Table 56. Celgene Anti-tumor Drug Product Overview
Table 57. Celgene Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Celgene Anti-tumor Drug SWOT Analysis
Table 59. Celgene Business Overview
Table 60. Celgene Recent Developments
Table 61. Bristol-Myers Squibb Anti-tumor Drug Basic Information
Table 62. Bristol-Myers Squibb Anti-tumor Drug Product Overview
Table 63. Bristol-Myers Squibb Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Recent Developments
Table 66. Amgen Anti-tumor Drug Basic Information
Table 67. Amgen Anti-tumor Drug Product Overview
Table 68. Amgen Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Amgen Business Overview
Table 70. Amgen Recent Developments
Table 71. Johnson and Johnson Anti-tumor Drug Basic Information
Table 72. Johnson and Johnson Anti-tumor Drug Product Overview
Table 73. Johnson and Johnson Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Johnson and Johnson Business Overview
Table 75. Johnson and Johnson Recent Developments
Table 76. Pfizer Anti-tumor Drug Basic Information
Table 77. Pfizer Anti-tumor Drug Product Overview
Table 78. Pfizer Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Pfizer Business Overview
Table 80. Pfizer Recent Developments
Table 81. Takeda Anti-tumor Drug Basic Information
Table 82. Takeda Anti-tumor Drug Product Overview
Table 83. Takeda Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Takeda Business Overview
Table 85. Takeda Recent Developments
Table 86. Eli Lilly Anti-tumor Drug Basic Information
Table 87. Eli Lilly Anti-tumor Drug Product Overview
Table 88. Eli Lilly Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Eli Lilly Business Overview
Table 90. Eli Lilly Recent Developments
Table 91. AstraZeneca Anti-tumor Drug Basic Information
Table 92. AstraZeneca Anti-tumor Drug Product Overview
Table 93. AstraZeneca Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Recent Developments
Table 96. Astellas Anti-tumor Drug Basic Information
Table 97. Astellas Anti-tumor Drug Product Overview
Table 98. Astellas Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Astellas Business Overview
Table 100. Astellas Recent Developments
Table 101. Merck and Co Anti-tumor Drug Basic Information
Table 102. Merck and Co Anti-tumor Drug Product Overview
Table 103. Merck and Co Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Merck and Co Business Overview
Table 105. Merck and Co Recent Developments
Table 106. Sanofi Anti-tumor Drug Basic Information
Table 107. Sanofi Anti-tumor Drug Product Overview
Table 108. Sanofi Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Sanofi Business Overview
Table 110. Sanofi Recent Developments
Table 111. Bayer Anti-tumor Drug Basic Information
Table 112. Bayer Anti-tumor Drug Product Overview
Table 113. Bayer Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Bayer Business Overview
Table 115. Bayer Recent Developments
Table 116. Biogen Idec Anti-tumor Drug Basic Information
Table 117. Biogen Idec Anti-tumor Drug Product Overview
Table 118. Biogen Idec Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Biogen Idec Business Overview
Table 120. Biogen Idec Recent Developments
Table 121. Eisai Anti-tumor Drug Basic Information
Table 122. Eisai Anti-tumor Drug Product Overview
Table 123. Eisai Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Eisai Business Overview
Table 125. Eisai Recent Developments
Table 126. Teva Anti-tumor Drug Basic Information
Table 127. Teva Anti-tumor Drug Product Overview
Table 128. Teva Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Teva Business Overview
Table 130. Teva Recent Developments
Table 131. Otsuka Anti-tumor Drug Basic Information
Table 132. Otsuka Anti-tumor Drug Product Overview
Table 133. Otsuka Anti-tumor Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Otsuka Business Overview
Table 135. Otsuka Recent Developments
Table 136. Global Anti-tumor Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 137. Global Anti-tumor Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 138. North America Anti-tumor Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 139. North America Anti-tumor Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 140. Europe Anti-tumor Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 141. Europe Anti-tumor Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 142. Asia Pacific Anti-tumor Drug Sales Forecast by Region (2025-2030) & (K Units)
Table 143. Asia Pacific Anti-tumor Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 144. South America Anti-tumor Drug Sales Forecast by Country (2025-2030) & (K Units)
Table 145. South America Anti-tumor Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 146. Middle East and Africa Anti-tumor Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 147. Middle East and Africa Anti-tumor Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 148. Global Anti-tumor Drug Sales Forecast by Type (2025-2030) & (K Units)
Table 149. Global Anti-tumor Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 150. Global Anti-tumor Drug Price Forecast by Type (2025-2030) & (USD/Unit)
Table 151. Global Anti-tumor Drug Sales (K Units) Forecast by Application (2025-2030)
Table 152. Global Anti-tumor Drug Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Anti-tumor Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-tumor Drug Market Size (M USD), 2019-2030
Figure 5. Global Anti-tumor Drug Market Size (M USD) (2019-2030)
Figure 6. Global Anti-tumor Drug Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-tumor Drug Market Size by Country (M USD)
Figure 11. Anti-tumor Drug Sales Share by Manufacturers in 2023
Figure 12. Global Anti-tumor Drug Revenue Share by Manufacturers in 2023
Figure 13. Anti-tumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-tumor Drug Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-tumor Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-tumor Drug Market Share by Type
Figure 18. Sales Market Share of Anti-tumor Drug by Type (2019-2024)
Figure 19. Sales Market Share of Anti-tumor Drug by Type in 2023
Figure 20. Market Size Share of Anti-tumor Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-tumor Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-tumor Drug Market Share by Application
Figure 24. Global Anti-tumor Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-tumor Drug Sales Market Share by Application in 2023
Figure 26. Global Anti-tumor Drug Market Share by Application (2019-2024)
Figure 27. Global Anti-tumor Drug Market Share by Application in 2023
Figure 28. Global Anti-tumor Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-tumor Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Anti-tumor Drug Sales Market Share by Country in 2023
Figure 32. U.S. Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Anti-tumor Drug Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-tumor Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Anti-tumor Drug Sales Market Share by Country in 2023
Figure 37. Germany Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Anti-tumor Drug Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Anti-tumor Drug Sales Market Share by Region in 2023
Figure 44. China Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Anti-tumor Drug Sales and Growth Rate (K Units)
Figure 50. South America Anti-tumor Drug Sales Market Share by Country in 2023
Figure 51. Brazil Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Anti-tumor Drug Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Anti-tumor Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Anti-tumor Drug Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Anti-tumor Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Anti-tumor Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Anti-tumor Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Anti-tumor Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Anti-tumor Drug Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Anti-tumor Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-tumor Drug Market Size (M USD), 2019-2030
Figure 5. Global Anti-tumor Drug Market Size (M USD) (2019-2030)
Figure 6. Global Anti-tumor Drug Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Anti-tumor Drug Market Size by Country (M USD)
Figure 11. Anti-tumor Drug Sales Share by Manufacturers in 2023
Figure 12. Global Anti-tumor Drug Revenue Share by Manufacturers in 2023
Figure 13. Anti-tumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Anti-tumor Drug Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Anti-tumor Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Anti-tumor Drug Market Share by Type
Figure 18. Sales Market Share of Anti-tumor Drug by Type (2019-2024)
Figure 19. Sales Market Share of Anti-tumor Drug by Type in 2023
Figure 20. Market Size Share of Anti-tumor Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Anti-tumor Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Anti-tumor Drug Market Share by Application
Figure 24. Global Anti-tumor Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Anti-tumor Drug Sales Market Share by Application in 2023
Figure 26. Global Anti-tumor Drug Market Share by Application (2019-2024)
Figure 27. Global Anti-tumor Drug Market Share by Application in 2023
Figure 28. Global Anti-tumor Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Anti-tumor Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Anti-tumor Drug Sales Market Share by Country in 2023
Figure 32. U.S. Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Anti-tumor Drug Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Anti-tumor Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Anti-tumor Drug Sales Market Share by Country in 2023
Figure 37. Germany Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Anti-tumor Drug Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Anti-tumor Drug Sales Market Share by Region in 2023
Figure 44. China Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Anti-tumor Drug Sales and Growth Rate (K Units)
Figure 50. South America Anti-tumor Drug Sales Market Share by Country in 2023
Figure 51. Brazil Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Anti-tumor Drug Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Anti-tumor Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Anti-tumor Drug Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Anti-tumor Drug Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Anti-tumor Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Anti-tumor Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Anti-tumor Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Anti-tumor Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Anti-tumor Drug Market Share Forecast by Application (2025-2030)
